Catalyst Pharmaceuticals (CPRX) EBIT Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -170.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3,724.00 |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 421.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 421.00 |
| Dec 31, 2025 | -379.00 |
| Sep 30, 2025 | 510.00 |
| Jun 30, 2025 | 103.00 |
| Mar 31, 2025 | 1,727.00 |
| Dec 31, 2024 | 660.00 |
| Sep 30, 2024 | 7,577.00 |
| Jun 30, 2024 | -269.00 |
| Mar 31, 2024 | -1,418.00 |
| Dec 31, 2023 | -1,299.00 |
| Sep 30, 2023 | -8,007.00 |
| Jun 30, 2023 | -689.00 |
| Mar 31, 2023 | 141.00 |
| Dec 31, 2022 | 1,743.00 |
| Sep 30, 2022 | 490.00 |
| Jun 30, 2022 | 1,024.00 |
| Mar 31, 2022 | 785.00 |
| Dec 31, 2021 | 547.00 |
| Sep 30, 2021 | -97.00 |
| Jun 30, 2021 | 882.00 |
| Mar 31, 2021 | -427.00 |
| Dec 31, 2020 | 121.00 |
| Sep 30, 2020 | -489.00 |
| Jun 30, 2020 | -327.00 |
| Mar 31, 2020 | 4,466.00 |
| Dec 31, 2019 | 299,523.00 |